Natera, Inc.
NTRANASDAQHealthcare● Active
$216.97
+$1.66(+0.77%)
Market Cap$31.1B
P/E Ratio—
52W High$256.36
52W Low$131.811
Natera, Inc. (NTRA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NTRA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.56
Est. -$0.54 · -3.3%
Revenue
$0.70B
Est. $0.62B · +12.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
NTRA reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.49 | — | — | — | $0.66B | — |
| ▼ Q2 FY2026 | May 7, 2026 | -$0.54 | -$0.56 | -3.3% | $0.70B | $0.62B | +12.9% |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$0.51 | $0.35 | +168.3% | $0.67B | $0.60B | +10.2% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -$0.39 | -$0.64 | -65.9% | $0.59B | $0.51B | +15.3% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -$0.62 | -$0.74 | -20.2% | $0.55B | $0.48B | +14.8% |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.64 | -$0.50 | +21.9% | $0.50B | $0.45B | +12.5% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -$0.38 | -$0.41 | -7.6% | $0.48B | $0.44B | +9.3% |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.57 | -$0.26 | +54.4% | $0.44B | $0.36B | +21.7% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.49
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
-$0.56
EPS Est.
-$0.54
EPS Surpr.
-3.3%
Revenue
$0.70B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
$0.35
EPS Est.
-$0.51
EPS Surpr.
+168.3%
Revenue
$0.67B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$0.64
EPS Est.
-$0.39
EPS Surpr.
-65.9%
Revenue
$0.59B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
-$0.74
EPS Est.
-$0.62
EPS Surpr.
-20.2%
Revenue
$0.55B
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.50
EPS Est.
-$0.64
EPS Surpr.
+21.9%
Revenue
$0.50B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
-$0.41
EPS Est.
-$0.38
EPS Surpr.
-7.6%
Revenue
$0.48B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.26
EPS Est.
-$0.57
EPS Surpr.
+54.4%
Revenue
$0.44B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.60 | $0.62 | $0.64 | 5 |
| Q3 FY2028 | $0.42 | $0.43 | $0.44 | 5 |
| Q2 FY2028 | $0.30 | $0.31 | $0.32 | 6 |
| Q1 FY2028 | $0.20 | $0.21 | $0.22 | 3 |
| Q4 FY2027 | $0.10 | $0.10 | $0.10 | 2 |
| Q3 FY2027 | $-0.06 | $-0.06 | $-0.06 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.0B | $1.1B | $1.1B | 3 |
| Q3 FY2028 | $1.0B | $1.0B | $1.0B | 5 |
| Q2 FY2028 | $0.9B | $0.9B | $0.9B | 3 |
| Q1 FY2028 | $0.9B | $0.9B | $1.0B | 3 |
| Q4 FY2027 | $0.9B | $0.9B | $0.9B | 4 |
| Q3 FY2027 | $0.8B | $0.8B | $0.9B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -3.3% | $215.09 | $219.82 | +2.20% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +168.3% | $211.83 | $216.10 | +2.02% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -65.9% | $199.92 | $198.48 | -0.72% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -20.2% | $138.13 | $141.08 | +2.14% |
| ▲ Q2 FY2025 | May 8, 2025 | +21.9% | $160.10 | $162.57 | +1.54% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -7.6% | $160.56 | $156.61 | -2.46% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +54.4% | $133.97 | $135.12 | +0.86% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +56.5% | $100.36 | $107.70 | +7.31% |
Q2 FY2026+2.20%
Report Date
May 7, 2026
EPS Beat/Miss
-3.3%
Price Before
$215.09
Price After
$219.82
Q1 FY2026+2.02%
Report Date
Feb 26, 2026
EPS Beat/Miss
+168.3%
Price Before
$211.83
Price After
$216.10
Q4 FY2025-0.72%
Report Date
Nov 6, 2025
EPS Beat/Miss
-65.9%
Price Before
$199.92
Price After
$198.48
Q3 FY2025+2.14%
Report Date
Aug 7, 2025
EPS Beat/Miss
-20.2%
Price Before
$138.13
Price After
$141.08
Q2 FY2025+1.54%
Report Date
May 8, 2025
EPS Beat/Miss
+21.9%
Price Before
$160.10
Price After
$162.57
Q1 FY2025-2.46%
Report Date
Feb 27, 2025
EPS Beat/Miss
-7.6%
Price Before
$160.56
Price After
$156.61
Q4 FY2024+0.86%
Report Date
Nov 12, 2024
EPS Beat/Miss
+54.4%
Price Before
$133.97
Price After
$135.12
Q3 FY2024+7.31%
Report Date
Aug 8, 2024
EPS Beat/Miss
+56.5%
Price Before
$100.36
Price After
$107.70
Avg Beat Reaction+2.93%
Avg Miss Reaction+0.29%
Beat Rate4 / 8 quarters
Largest Move+7.31% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NTRA ends December
Natera, Inc. (NTRA) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.56 — missing the analyst consensus of $-0.54 by -3.3%. The next NTRA earnings date is expected around September 1, 2026.
Each quarter, investors track NTRA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NTRA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NTRA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NTRA earnings · 5 questionsNatera, Inc.'s next earnings report is expected around September 1, 2026. NTRA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NTRA historically reports after market close (AMC).
NTRA earnings datewhen is NTRA earningsNTRA next earnings datewhen does NTRA report earningsNTRA earnings calendar
▸ Source: FMP · Natera, Inc. SEC filings · US GAAP · Natera, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026